CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of CAD 114.80 billion. The enterprise value is 211.06 billion.

Market Cap	114.80B
Enterprise Value	211.06B

Important Dates

The last earnings date was Thursday, May 1, 2025.

Earnings Date	May 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.77%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.26B

Valuation Ratios

The trailing PE ratio is 15.13 and the forward PE ratio is 10.37.

PE Ratio	15.13
Forward PE	10.37
PS Ratio	0.21
PB Ratio	1.04
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.89, with an EV/FCF ratio of 24.72.

EV / Earnings	27.81
EV / Sales	0.40
EV / EBITDA	8.89
EV / EBIT	16.15
EV / FCF	24.72

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 1.05.

Current Ratio	0.82
Quick Ratio	0.59
Debt / Equity	1.05
Debt / EBITDA	4.79
Debt / FCF	13.67
Interest Coverage	3.08

Financial Efficiency

Return on equity (ROE) is 6.93% and return on invested capital (ROIC) is 3.71%.

Return on Equity (ROE)	6.93%
Return on Assets (ROA)	2.31%
Return on Invested Capital (ROIC)	3.71%
Return on Capital Employed (ROCE)	5.60%
Revenue Per Employee	2.09M
Profits Per Employee	29,246
Employee Count	300,000
Asset Turnover	1.49
Inventory Turnover	19.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.03% in the last 52 weeks. The beta is 0.57, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+13.03%
50-Day Moving Average	16.46
200-Day Moving Average	14.73
Relative Strength Index (RSI)	41.73
Average Volume (20 Days)	985,978

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.58

Income Statement

In the last 12 months, CVS Health had revenue of CAD 541.51 billion and earned 7.59 billion in profits. Earnings per share was 6.02.

Revenue	541.51B
Gross Profit	73.33B
Operating Income	13.42B
Pretax Income	10.33B
Net Income	7.59B
EBITDA	20.05B
EBIT	13.42B
Earnings Per Share (EPS)	6.02

Full Income Statement

Balance Sheet

The company has 18.19 billion in cash and 116.73 billion in debt, giving a net cash position of -98.54 billion.

Cash & Cash Equivalents	18.19B
Total Debt	116.73B
Net Cash	-98.54B
Net Cash Per Share	n/a
Equity (Book Value)	110.83B
Book Value Per Share	87.62
Working Capital	-22.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.59 billion and capital expenditures -4.05 billion, giving a free cash flow of 8.54 billion.

Operating Cash Flow	12.59B
Capital Expenditures	-4.05B
Free Cash Flow	8.54B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 13.54%, with operating and profit margins of 2.48% and 1.40%.

Gross Margin	13.54%
Operating Margin	2.48%
Pretax Margin	1.91%
Profit Margin	1.40%
EBITDA Margin	3.70%
EBIT Margin	2.48%
FCF Margin	1.58%

Dividends & Yields

CVS Health does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	63.88%
Buyback Yield	1.77%
Shareholder Yield	1.77%
Earnings Yield	6.61%
FCF Yield	7.44%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.12. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.12
Piotroski F-Score	n/a